Tag: biotechnology
-
Early Results Show Anti-Depressive Drug Effects
Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder.
-
Q3 Venture Investing Falls, Biotech Remains Hot
Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with declines occurring in the U.S. and worldwide.
-
Nanoparticles Designed to Cross Blood-Brain Barrier
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain.
-
Companies Developing Hemophilia Gene Editing Therapy
A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins.
-
Merck Gaining Gut Microbe Technology for Vaccines
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines.
-
Peanut Allergy Patch Under FDA Review
A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration.
-
Dementia Drug Candidate in Preclinical Tests
A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease.
-
Small Biz Grant Funds Prenatal Genetic Test
A small business set-aside grant is funding early development of a non-invasive prenatal test that simplifies detection of genetic abnormalities in a fetus.
-
Nanotech Crispr Delivery in Development
Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment.
-
Novartis, Microsoft Partner on A.I.
Drug maker Novartis is collaborating with Microsoft to extend the company’s adoption of artificial intelligence into many of its corporate functions.